AVEO Pharmaceuticals

AVEO is a biopharmaceutical company focused on the discovery and development of drugs that target gene products critical for the maintenance and recurrence of established cancers. AVEO is positioned to revolutionize cancer drug discovery and development by employing powerful, proprietary genetic model systems to discover and develop drugs against essential targets critical to the origin, maintenance and spread of malignant tumors. This novel high-throughput in vivo technology platform enables the rapid functional identification and prioritization of only the most relevant drug targets – dramatically improving the efficiency of drug discovery. Additionally, by identifying patient populations likely to be responsive to drug therapy, AVEO’s technology enables smarter drug development, decreased development costs and improved attrition.